Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis.

[1]  D. Bharadwaj,et al.  The Major Receptor for C-Reactive Protein on Leukocytes Is Fcγ Receptor II , 1999 .

[2]  R. Ashman,et al.  Fc receptor off-signal in the B cell involves apoptosis. , 1996, Journal of immunology.

[3]  M. Pepys,et al.  C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction , 1999, The Journal of experimental medicine.

[4]  J. Rossi,et al.  C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma. , 1998, Leukemia & lymphoma.

[5]  Zander,et al.  High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. , 1986, Blood.

[6]  B. Barlogie,et al.  Primary dexamethasone treatment of multiple myeloma. , 1992 .

[7]  A. Tienhaara,et al.  Serum immunoreactive interleukin‐6 and C‐reactive protein levels in patients with multiple myeloma at diagnosis , 1994, British journal of haematology.

[8]  T. Vogt,et al.  Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far‐advanced melanoma and soft tissue sarcoma , 2004, Cancer.

[9]  L. Pedersen,et al.  Urinary Albumin Excretion and its Relationship to C-reactive Protein and Proinflammatory Cytokines in Patients with Cancer and Febrile Neutropenia , 2003, Scandinavian journal of infectious diseases.

[10]  T. Kurosaki,et al.  Deletion of SHIP or SHP-1 Reveals Two Distinct Pathways for Inhibitory Signaling , 1997, Cell.

[11]  Michael L. Wang,et al.  Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies. , 2006, Cancer cell.

[12]  L. Rabbani,et al.  Evidence for C-Reactive Protein's Role in (CRP) Vascular Disease: Atherothrombosis, Immuno-Regulation and CRP , 2004, Journal of Thrombosis and Thrombolysis.

[13]  Lewis C Cantley,et al.  PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.

[14]  D. Schenkein,et al.  Phase I/II trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Filep,et al.  Loss of Pentameric Symmetry of C-reactive Protein Is Associated with Delayed Apoptosis of Human Neutrophils* , 2002, The Journal of Biological Chemistry.

[16]  B. Barlogie,et al.  Cancer and the Microenvironment , 2004, Cancer Research.

[17]  R. Crowell,et al.  C-reactive protein receptors on the human monocytic cell line U-937. Evidence for additional binding to Fc gamma RI. , 1991, Journal of immunology.

[18]  B. Barlogie,et al.  Serial measurement of serum C-reactive protein levels can identify patients at risk for severe complications following autologous stem cell transplantation , 2005, Leukemia & lymphoma.

[19]  K. Anderson,et al.  Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. , 1993, Blood.

[20]  D. Bharadwaj,et al.  C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. , 2000, The Journal of clinical investigation.

[21]  S. Devaraj,et al.  Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role , 2005, Current opinion in nephrology and hypertension.

[22]  H. Asaoku,et al.  Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas , 1988, Nature.

[23]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[24]  M. Pepys.  C-reactive protein: the role of an ancient protein in modern rheumatology. , 1983, Clinical and experimental rheumatology.

[25]  N. Caplen,et al.  Short Interfering RNA (siRNA)—Mediated RNA Interference (RNAi) in Human Cells , 2003, Annals of the New York Academy of Sciences.

[26]  A. Agrawal,et al.  Transactivation of C-Reactive Protein by IL-6 Requires Synergistic Interaction of CCAAT/Enhancer Binding Protein β (C/EBPβ) and Rel p501 , 2001, The Journal of Immunology.

[27]  J. Kemp,et al.  Human C-Reactive Protein Increases Cerebral Infarct Size after Middle Cerebral Artery Occlusion in Adult Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  Elizabeth Yang,et al.  Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[29]  B. Klein,et al.  C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. , 1992, Blood.

[30]  M. Takemura,et al.  Serum‐soluble Fas level determines clinical symptoms and outcome of patients with aggressive non‐Hodgkin's lymphoma , 2000, American journal of hematology.

[31]  B. Barlogie,et al.  Primary Myeloma Cells Growing in SCID-hu Mice: A Model for Studying the Biology and Treatment of Myeloma and Its Manifestations , 1998 .

[32]  V. Diehl,et al.  Elevation of circulating IL‐6 in patients with acute non‐lymphocytic leukemia , 1994, European journal of haematology.

[33]  T. Kinoshita,et al.  Elevated serum interleukin‐6 (IL‐6) is derived from neoplastic lymphoid cells in patients with B‐cell non‐Hodgkin's lymphoma: correlation with extent of IL‐6 expression and serum concentration , 1996, British journal of haematology.

[34]  A. Berrebi,et al.  Secretion of pro‐apoptotic intron 4‐retaining soluble HLA‐G1 by human villous trophoblast , 2002, European journal of immunology.

[35]  L. Marnell,et al.  C-reactive protein binds to Fc gamma RI in transfected COS cells. , 1995, Journal of immunology.

[36]  Kazuhiro Nakamura,et al.  Transcriptional Regulation of Fcgr2b Gene by Polymorphic Promoter Region and Its Contribution to Humoral Immune Responses1 , 2002, The Journal of Immunology.

[37]  D. Neuberg,et al.  Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model. , 2002, Cancer research.

[38]  S. Korsmeyer,et al.  Involvement of Microtubules in the Regulation of Bcl2 Phosphorylation and Apoptosis through Cyclic AMP-Dependent Protein Kinase , 1998, Molecular and Cellular Biology.

[39]  F. Lemonnier,et al.  Identification of HLA-A*0201-restricted cytotoxic T-cell epitopes of Trypanosoma cruzi TcP2beta protein in HLA-transgenic mice and patients. , 2003, Microbes and infection.

[40]  B. Barlogie,et al.  Interleukin-6 prevents dexamethasone-induced myeloma cell death. , 1994, Blood.